Abstract: A martensitic stainless alloy comprising, in percent by weight (wt. %) C >0.50 to 0.60; Si 0.10 to 0.60, Mn 0.40 to 0.80; Cr 13.50 to 14.50; Ni 0 to 1.20; Mo 0.80 to 2.50; N 0.050 to 0.12; Cu 0.10 to 1.50; V max 0.10; S max 0.03; P max 0.03; the balance being Fe an unavoidable impurities.

Abstract: The present disclosure relates to a duplex stainless steels strip manufactured from a duplex stainless steel, wherein the duplex stainless steel comprises the following composition, in weight %: C less than or equal to 0.02; Si 0.05 to 0.40; Mn 0.5-3.0; Cr 30.0 to 33.0; Ni 5.0-10.0; Mo 2.0-4.0; N 0.40-0.60; Al 0.010-0.035; B 0.0020-0.0030; Ca 0.0006-0.0040; 5 Cu 0-0.60; V0-0.15; W 0-0.05; Co 0-0.60; Ti 0-0.03; Nb 0-0.03; P less than or equal to 0.03; S less than or equal to 0.02; balance Fe and unavoidable impurities; and wherein the duplex stainless steel consists of 30-70 vol % austenite phase and 70-30 vol % ferrite phase; and wherein the strip has alternating layers of ferrite phase and austenite phase, said alternating layers are essentially parallel with the plane of the object and said alternating 10 layers have an average layer thickness less than or equal to about 10 ?m. The present disclosure also relates to a method of producing a strip comprising said duplex stainless steel.

Abstract: The present disclosure relates to a duplex stainless steels strip manufactured from a duplex stainless steel, wherein the duplex stainless steel comprises the following composition, in weight %: C less than or equal to 0.02; Si 0.05 to 0.40; Mn 0.5-3.0; Cr 30.0 to 33.0; Ni 5.0-10.0; Mo 2.0-4.0; N 0.40-0.60; Al 0.010-0.035; B 0.0020-0.0030; Ca 0.0006-0.0040; 5 Cu 0-0.60; V0-0.15; W 0-0.05; Co 0-0.60; Ti 0-0.03; Nb 0-0.03; P less than or equal to 0.03; S less than or equal to 0.02; balance Fe and unavoidable impurities; and wherein the duplex stainless steel consists of 30-70 vol % austenite phase and 70-30 vol % ferrite phase; and wherein the strip has alternating layers of ferrite phase and austenite phase, said alternating layers are essentially parallel with the plane of the object and said alternating 10 layers have an average layer thickness less than or equal to about 10 ?m. The present disclosure also relates to a method of producing a strip comprising said duplex stainless steel.

Abstract: The invention relates to an electrical contact t comprising a strip substrate comprising a conductive layer of a metal or an alloy provided on the surface of the substrate and an oxide layer provided on the conductive layer. By means of the oxide layer the underlying metal or alloy layer is protected from reaction with elements such as oxide or sulphur in the ambient air. The invention also relates to products such as fuel cells and solar cells comprising the electrical contact.

Abstract: The invention relates to a coated product comprising a strip substrate comprising a conductive alloy layer comprising silver and indium provided on the surface of the substrate. The conductive alloy layer has good electrical properties and does not easily react with sulphur in the ambient air. The invention further relates to a method for producing a coated product, comprising the steps of: providing a strip substrate; ion-etching of the substrate; depositing a conductive alloy layer comprising silver and indium on the substrate. The invention also relates to a product for electrical use comprising the coated product.

Abstract: The present invention relates to a process for purifying apolipoprotein A (ApoA) or apolipoprotein E (ApoE) from human plasma, by obtaining a fraction of human plasma containing said ApoA or ApoE, prepurifying said fraction in at least one step, binding said ApoA or ApoE to an anion-exchange chromatography gel, and thereafter eluting said ApoA or ApoE from said anion-exchange chromatography gel. The thus produced ApoA or ApoE can be used for the manufacture of a medicament in the treatment of atherosclerosis and cardiovascular diseases, or peripheral atherosclerosis and sepsis as well as in a method for treatment of atherosclerosis and cardiovascular diseases, or peripheral atherosclerosis and sepsis when administered in a therapeutically effective amount.

Abstract: The present invention relates to a process for purifying apolipoprotein A (ApoA) or apolipoprotein E (ApoE) from human plasma, by obtaining a fraction of human plasma containing said ApoA or ApoE, prepurifying said fraction in at least one step, binding said ApoA or ApoE to an anion-exchange chromatography gel, and thereafter eluting said ApoA or ApoE from said anion-exchange chromatography gel. The thus produced ApoA or ApoE can be used for the manufacture of a medicament in the treatment of atherosclerosis and cardiovascular diseases, or peripheral atherosclerosis and sepsis as well as in a method for treatment of atherosderosis and cardiovascular diseases, or peripheral atherosclerosis and sepsis when administered in a therapeutically effective amount.